作者单位:
Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
[1]
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
[2]
Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
[3]
Provincial System Support Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
[4]
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
[5]
Pharmacy Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
[6]
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
[7]
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
[8]
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
[9]
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
[10]
Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
[11]
Acute Care Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
[12]
Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
[13]
Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada.
[14]
Office of Drug Research and Surveillance, Controlled Substances and Cannabis Branch, Health Canada, Ottawa, Ontario, Canada.
[15]
DOI
10.1080/10826084.2024.2330892
PMID
38503716
发布时间
2024-04-25